Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs
- 27 Downloads
The effects of intravenous administration of propionyl-L-carnitine (PLC) were investigated in anesthetized dogs instrumented for the analysis of general hemodynamic and electrocardiographic data, peripheral blood flows, coronary blood flow and oxygen consumption, urine flow, and renal function. PLC was administered in bolus (20, 60, and 200 mg/kg) or by infusion (20 mg/kg/min * 15 min or 30 mg/kg/min * 10 min). In some cases also L-carnitine (LC) and L-carnitine + propionate (LC + P) were administered in doses equimolar to those of PLC. PLC elicited dose-dependent, short-lasting enhancements of cardiac output, both in open-and close-chest conditions. Arterial blood pressure, heart rate, and contractility varied slightly and unpredictably; the substance did not elicit electrocardiographic effects. These responses were not changed by alpha- or beta-adrenergic blockade, nor by the administration of a calcium antagonist, but they were abolished or reversed by the combination of such blocking interventions. Mesenteric and iliac blood flows were increased by both PLC and LC; LC + P increased these, and in addition increased renal blood flow. A strong diuresis obtained with PLC, LC, and LC + P was due to osmotic clearance following the administration of hyperosmotic solutions. PLC elicited coronary vasodilation with reduced oxygen extraction; this effect lasted longer than the general hemodynamic effects and was not seen with LC. All the cardiovascular actions of PLC can be attributed to its pharmacologic properties, rather than to its role as a metabolic intermediate.
Key Wordspropionyl-L-carnitine L-carnitine peripheral vasodilation, coronary flow
Unable to display preview. Download preview PDF.
- 5.Kotaka K, Miyazaki Y, Kouichi O, et al. Protective effects of carnitine and its derivatives against free fatty acid-induced mitochondrial dysfunction. J Appl Biochem 1981;3:328–336.Google Scholar
- 7.Hotta R, Sugiyama S, Nagai S, et al. Effects of l-carnitine and l-propionylcarnitine on ischemia-induced mitochondrial dysfunction. J Mol Cell Cardiol 1983;15:S1 n.114.Google Scholar
- 8.Curello S, Carnioni A, Ceconi C, Ferrari R. Effects of L-carnitine derivatives on lipid peroxidation of cardiac mitochondria. In: Physiology, clinical aspects and treatment of Coronary Insufficiency. An International Symposium, Torino 1987.Google Scholar
- 12.Aomine M, Arita M, Imanishi S, et al. Effects of l-propionyl carnitine on electrical and mechanical properties of guinea pig ventricular muscle and canine Purkinje fibers. J Mol Cell Cardiol 1983;15:S5 n.14.Google Scholar
- 13.Cevese A, Blonda P. Analisi automatica di dati emodinamici: prime realizzazioni. Boll Soc It Biol Sper 1983;59:257–263.Google Scholar
- 14.Cevese A. Automatic elaboration of hemodynamic data. In: Lown B, Malliani A, Prosdocimi M, eds. Neural mechanisms and cardiovascular disease. Padova: Liviana Press, 1985:553–554.Google Scholar
- 22.Bongrani S, DiLisa F, Raddino R, et al. D,L-carnitine and D,L-acetylcarnitine actions on myocardial contractility and coronary resistance in isolated perfused rabbit hearts. Il Farmaco 1980;35:239–248.Google Scholar